Return on Equity: The amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested. Calculated as: Income from Continuing Operations / Total Common Equity
Prime Medicine, Inc. (PRME) had Return on Equity of -31.26% for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
$1.23M |
|
$-50.58M |
|
-- |
|
$1.23M |
|
$55.20M |
|
$-53.97M |
|
$3.39M |
|
$-50.58M |
|
$-51.33M |
|
$-50.58M |
|
$-50.58M |
|
$-50.58M |
|
$-51.33M |
|
$-53.97M |
|
$-52.67M |
|
160.50M |
|
160.50M |
|
$-0.32 |
|
$-0.32 |
|
| Balance Sheet Financials | |
$231.41M |
|
$22.05M |
|
$153.61M |
|
$385.01M |
|
$35.02M |
|
-- |
|
$188.17M |
|
$223.19M |
|
$161.82M |
|
$161.82M |
|
$161.82M |
|
180.31M |
|
| Cash Flow Statement Financials | |
$-125.31M |
|
$-137.09M |
|
$150.95M |
|
$196.54M |
|
$85.09M |
|
$-111.45M |
|
$24.75M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
6.61 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-4405.96% |
|
-4405.96% |
|
-- |
|
-4129.14% |
|
-4129.14% |
|
$-129.55M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
-- |
|
-- |
|
|
Return on Equity |
-31.26% |
-31.26% |
|
-13.14% |
|
-31.26% |
|
$0.90 |
|
$-0.81 |
|
$-0.78 |
|